Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis

Illumina, Inc. (NASDAQ:ILMN) has introduced PromoterAI, a breakthrough AI tool designed to detect disease-causing mutations in the noncoding promoter regions of the genome, areas often overlooked in clinical diagnostics. Featured in Science, the study shows PromoterAI could explain up to 6% of undiagnosed rare disease cases, potentially doubling diagnostic success when paired with existing AI tools.

A…